Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Microbial Identification via Biochemical Testing – V 2.0

Posted on By

Analytical Method Development: SOP for Microbial Identification via Biochemical Testing – V 2.0

Standard Operating Procedure for Microbial Identification Using Biochemical Testing in AMD


Department Analytical Method Development
SOP No. SOP/AMD/222/2025
Supersedes SOP/AMD/222/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP outlines the standardized procedure for identifying bacteria and fungi using biochemical testing techniques, including the use of commercial identification kits and confirmatory manual tests, for characterization of

microbial isolates from pharmaceutical environments or product samples.

2. Scope

This procedure applies to microbial isolates obtained during preservative efficacy testing, environmental monitoring, water testing, and product sterility assessments within the Analytical Method Development (AMD) department.

3. Responsibilities

  • Microbiologist: Prepares inoculum, performs biochemical identification tests, and interprets results.
  • Lab Assistant: Assists in media preparation, incubation, and maintenance of microbial stock cultures.
  • Group Leader: Reviews and approves identification reports.
  • QA Executive: Verifies adherence to procedures and ensures test results are documented in line with regulatory expectations.
See also  Analytical Method Development: SOP for Swab Sampling Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring accurate and validated identification of microbial contaminants or isolates using approved biochemical test procedures.

5. Procedure

5.1 Culture Preparation

  1. Revive microbial isolate on appropriate solid media (e.g., Nutrient Agar, Sabouraud Dextrose Agar).
  2. Incubate at 30–35°C for bacteria and 20–25°C for fungi for 24–72 hours as appropriate.
  3. Confirm purity of isolate by streaking on fresh media before identification.

5.2 Biochemical Identification

  1. Use commercial biochemical test kits (e.g., HiBac™, API™, or equivalent).
    • For Gram-negative bacteria: Use enteric identification systems.
    • For Gram-positive cocci: Use catalase, coagulase, and salt tolerance tests.
    • For yeasts: Use sugar assimilation and urease tests.
  2. Follow manufacturer’s protocol for:
    • Inoculum preparation (0.5 McFarland standard)
    • Inoculation and incubation
    • Reading color reactions or turbidity results
  3. Enter results into software or coding charts provided by the kit manufacturer.
See also  Analytical Method Development: SOP for Handling and Qualification of Analytical Reference Standards - V 2.0

5.3 Manual Confirmatory Tests (if required)

  1. Perform manual tests such as:
    • Indole, Methyl Red, Voges-Proskauer, Citrate (IMViC)
    • Triple Sugar Iron (TSI) slants
    • Oxidase, Catalase, Urease tests
  2. Use positive and negative control organisms for each test.
  3. Record observations with interpretation in Annexure-1.

5.4 Data Recording and Interpretation

  1. Record biochemical profiles in the template provided (Annexure-2).
  2. Report identification up to genus and species level where possible.
  3. Document uncertainty in identification and recommend re-confirmation if required.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • API™: Analytical Profile Index
  • CFU: Colony Forming Units
  • IMViC: Indole, Methyl Red, Voges-Proskauer, Citrate

7. Documents

  1. Manual Biochemical Test Result Log – Annexure-1
  2. Identification Result Report Template – Annexure-2
  3. Biochemical Kit Lot and Expiry Tracker – Annexure-3

8. References

  • USP <62> Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms
  • Indian Pharmacopoeia: Microbiological Tests
  • Manufacturer protocols for HiMedia™, bioMérieux™, or equivalent kits

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Meena Joshi Deepak Goyal Sunita Reddy
Designation Microbiologist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Manual Biochemical Test Result Log

Test Result Interpretation Controls Used
Indole Positive Escherichia coli E. coli (Positive), S. aureus (Negative)

Annexure-2: Identification Result Report

Sample ID Biochemical Kit Used Profile Code Organism Identified Confidence Level
ISO-23-001 API 20E 5144772 Enterobacter cloacae 99.5%

Annexure-3: Kit Lot and Expiry Record

Kit Name Manufacturer Lot No. Expiry Date Status
HiBac™ GN ID HiMedia HB2345 31/08/2025 Active

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Integrated biochemical test kits and added confirmatory test annexures Annual Review and Audit Update Sunita Reddy
10/05/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Linearity Study Using UV - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Using Visual Aids (Flowcharts, Diagrams) in SOPs for Better Understanding
Next Post: Sterile Injectable Manufacturing: SOP for Calibration of Lyophilizers in Injectable Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version